Although PPARγ ligands inhibitxenografted human tumors [1, 33], in one study using mousemodel of colon cancer (APC/Min) PPARγ ligands increased the number ofprecancerous polyps, tumor frequency and size [81]. This evidence concerns the gene PPARG and malignant colon neoplasm.